Invest In Biomed program

The Invest In Biomed Class of 2025 is launched!

This unique program helps selected startups to structure their fundraising and meet investors specialized in their sector.

Benefits for Invest In Biomed 2025 startups

  • Direct their communications to convince investors
  • Get personalized feedback on the content and form of their pitch deck from experienced healthcare fundraising professionals
  • Be coached on their oral performance
  • Present their project to a panel of investors specialized in their field
  • Establish or consolidate links with these investors and obtain their qualitative feedback on their project
  •  

 

 

The Invest In Biomed program

6 group or individual workshops from March to June 2025, led by healthcare and fundraising experts

Flash review of your project

A 360° analysis of your project, based on a deck review and two interviews

Speakers: experts from the Eurobiomed team

Understand investors' expectations and how they invest

Speakers : Healthcare VCs

Work on your equity story and deck

Speakers: healthcare fundraising experts

Working on your oral presentation

Speaker: communications consultant

Health investment day

Pitch presentations by project leaders and investors
BtoB networking session

Preparing the next stages of your lift

Debriefing of investor meetings
Preparing for the next steps in your fundraising process

Speakers: experts from the Eurobiomed team

Read the testimonials of 4 startups supported by Invest In Biomed

A look back at 2024 

Class of 2024 healthcare fundraising experts

  • Sofia ARNAL - Associate AdBio Partners, trained pharmacist
  • Sophie BRAUN - Health consultant In Extenso Croissance
  • Karine CHORRO - Phost'In Therapeutics, CEO and co-founder, ex deputy director Genepep
  • Stéphane DEBONO - Former Deputy CEO and VP HalioDx
  • Vincent FERT - Partner Turenne Groupe, former CEO/President HalioDx
  • Pierre HORNUS - CEO/Co-founder Semeia
  • Francine LANCELEUR BRENNING - Qualitalents Director, former General Manager/BD MediHandTrace
  • Laure Hélène MERCIER - LH Mercier Conseil, consultant in fund raising, IPO, ex CFO Innate Pharma
  • Claire NAUSSAC - Operating partner Truffle Capital
  • Claire VERSCHELDE - ICOSA, Co-founding partner, IP specialist
  • Grégory VOISIN - CEO and founder of ToxiPlan

 

Investors in the Class of 2024

Program partners

Invest In Biomed is supported by the Occitanie Region and the European Union via the FEDER fund.

Our backers

 

For more information

Contact us!

J
No results found.